Blood transfusion
Blood transfusion ( 30 Questions)
Which alternative to blood transfusion may be considered for patients with symptomatic anemia and ongoing bleeding?
Whole blood. Rationale: Whole blood contains all blood components, including red blood cells, plasma, platelets, and clotting factors. It is used for patients with symptomatic anemia and ongoing bleeding, as it can address both the anemia and provide clotting factors to assist in hemostasis.
Packed red blood cells (PRBCs) Rationale: Packed red blood cells are primarily used to increase the oxygen-carrying capacity in patients with anemia or significant blood loss. While they can address the anemia component of the patient's condition, they do not provide clotting factors. Therefore, they may not be the best choice for patients with ongoing bleeding.
Fresh frozen plasma (FFP) Rationale: Fresh frozen plasma is rich in clotting factors and is used to treat bleeding disorders or clotting factor deficiencies. It can be beneficial for patients with bleeding issues but does not address the anemia component of the patient's condition.
Platelets. Rationale: Platelets are responsible for clot formation and are primarily used to treat thrombocytopenia or clotting disorders. They do not address the anemia component of the patient's condition and are not typically considered an alternative to blood transfusion for anemic patients with ongoing bleeding. ABO and Rh Blood Group Systems:
Choice A rationale:
Whole blood.
Rationale: Whole blood contains all blood components, including red blood cells, plasma, platelets, and clotting factors.
It is used for patients with symptomatic anemia and ongoing bleeding, as it can address both the anemia and provide clotting factors to assist in hemostasis.
Choice B rationale:
Packed red blood cells (PRBCs)
Rationale: Packed red blood cells are primarily used to increase the oxygen-carrying capacity in patients with anemia or significant blood loss.
While they can address the anemia component of the patient's condition, they do not provide clotting factors.
Therefore, they may not be the best choice for patients with ongoing bleeding.
Choice C rationale:
Fresh frozen plasma (FFP)
Rationale: Fresh frozen plasma is rich in clotting factors and is used to treat bleeding disorders or clotting factor deficiencies.
It can be beneficial for patients with bleeding issues but does not address the anemia component of the patient's condition.
Choice D rationale:
Platelets.
Rationale: Platelets are responsible for clot formation and are primarily used to treat thrombocytopenia or clotting disorders.
They do not address the anemia component of the patient's condition and are not typically considered an alternative to blood transfusion for anemic patients with ongoing bleeding.
ABO and Rh Blood Group Systems: